# Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography

Study · id `cardio:ct-nct01848899` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01848899](<https://clinicaltrials.gov/study/NCT01848899>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01848899

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT01848899. Randomized; single masking. Start 2013-02 (registry gives no type); primary completion 2013-11 (actual). Results posted on 2016-04-06.

## Key facts

- Design: Interventional study; randomized; single masking
- Phase: Phase 4
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT01848899, source copy `cardio:ctgov-nct01848899-2016-04-06`, retrieved 2026-10-26)
- Start date: 2013-02 (registry gives no type) (ClinicalTrials.gov record NCT01848899, source copy `cardio:ctgov-nct01848899-2016-04-06`, retrieved 2026-10-26)
- Primary completion: 2013-11 (actual) (ClinicalTrials.gov record NCT01848899, source copy `cardio:ctgov-nct01848899-2016-04-06`, retrieved 2026-10-26)
- Completion: 2014-11 (actual) (ClinicalTrials.gov record NCT01848899, source copy `cardio:ctgov-nct01848899-2016-04-06`, retrieved 2026-10-26)
- Results first posted: 2016-04-06 (ClinicalTrials.gov record NCT01848899, source copy `cardio:ctgov-nct01848899-2016-04-06`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01848899, source copy `cardio:ctgov-nct01848899-2016-04-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01848899-2016-04-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography
- Condition: Coronary Artery Disease
- Intervention (Drug): Iodixanol
- Intervention (Drug): Ioxaglate
- Intervention (Drug): Bivalirudin
- Lead sponsor: NYU Langone Health
- Lead sponsor class: OTHER
- Collaborator: Guerbet
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record: Bivalirudin (`cardio:bivalirudin`)
- Registry lists this organization as the lead sponsor: NYU Langone Health (`cardio:org-nyu-langone-health`)
- Registry lists this organization as a collaborator: Guerbet (`cardio:org-guerbet`)

## Provenance

Content hash: aeef6405c3e7daf1e5879eafe7a2484f2971e86b1c15a1cc6a3a153dfb3bfa5b
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
